An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
Titel:
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
Auteur:
Chouaid, Christos Bosquet, Lise Girard, Nicolas Kron, Anna Scheffler, Matthias Griesinger, Frank Sebastian, Martin Trigo, Jose Viteri, Santiago Knott, Craig Rodrigues, Bernardo Rahhali, Nora Cabrieto, Jedelyn Diels, Joris Perualila, Nolen J. Schioppa, Claudio A. Sermon, Jan Toueg, Raphael Erdmann, Nicole Mielke, Janka Nematian-Samani, Mehregan Martin-Fernandez, Cristina Pfaira, Innocent Li, Tracy Mahadevia, Parthiv Wolf, Jürgen